Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 1/20 | 0.39 |
| ▸ | GIPR | P48546 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | UBE2M | P61081 | 1/20 | 0.38 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.38 |
| ▸ | RHOA | P61586 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20879839 | 1.00 | GCGR (0.39) | GCGRGIPRRXFP1HSD11B1HSD17B1 | |
| SCHEMBL14960510 | 1.00 | GCGR (0.39) | GCGRGIPRRXFP1HSD11B1HSD17B1 | |
| SCHEMBL14959102 | 0.94 | UBE2M (0.40) | GCGRGIPRRXFP1HSD11B1HSD17B1 | |
| SCHEMBL14960509 | 0.91 | RXFP1 (0.42) | GCGRGIPRRXFP1UBE2MDCUN1D1 | |
| SCHEMBL18790161 | 0.91 | RXFP1 (0.42) | GCGRGIPRRXFP1UBE2MDCUN1D1 | |
| SCHEMBL13327392 | 0.91 | RXFP1 (0.42) | GCGRGIPRRXFP1UBE2MDCUN1D1 | |
| SCHEMBL15088237 | 0.90 | RXFP1 (0.37) | GCGRGIPRRXFP1UBE2MDCUN1D1 | |
| SCHEMBL15088254 | 0.88 | EPHX2 (0.39) | GCGRGIPRRXFP1MAPK1UBE2M | |
| SCHEMBL18790204 | 0.87 | MAPK14 (0.37) | GCGRGIPRRXFP1UBE2MDCUN1D1 | |
| SCHEMBL21163857 | 0.87 | MAPK14 (0.37) | GCGRGIPRRXFP1UBE2MDCUN1D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230102258-A1 | C5AR ANTAGONISTS | CHEMOCENTRYX, INC. | 2023-03-30 | — | — | US | disclosed |
| US-20170114017-A1 | C5AR ANTAGONISTS | CHEMOCENTRYX, INC. | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114017-A1 | C5AR ANTAGONISTS | C5AR1, C5AR2, C3AR1 | GCGR 574/4885GIPR 220/4885RXFP1 911/4885 |
| US-20230102258-A1 | C5AR ANTAGONISTS | C5AR1, C5AR2, C3AR1 | GCGR 574/4885GIPR 220/4885RXFP1 911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.